Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

AMBI to submit IND for nisin

May 8, 1997

FDA requests additional data to support Gilead's NDA for HSV treatment

May 8, 1997

MedImmune reports further clinical results for MEDI-493

May 8, 1997

Pharmacia & Upjohn prepares new antibacterial agents

May 8, 1997

N-Oxide oxazolidinones from Pharmacia & Upjohn

May 7, 1997

Salix to commence clinical trials with Normix

May 6, 1997

Gilead's cidofovir injection approved in the European Union

May 6, 1997

New ganciclovir derivative from Norsk Hydro for HSV infections

May 5, 1997

Clinical results for intravaginal dextrin sulfate gel

May 5, 1997

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...